Los Angeles Capital Management LLC Madrigal Pharmaceuticals, Inc. Transaction History
Los Angeles Capital Management LLC
- $28.5 Billion
- Q3 2025
A detailed history of Los Angeles Capital Management LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 5,124 shares of MDGL stock, worth $2.71 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,124
Previous 5,149
0.49%
Holding current value
$2.71 Million
Previous $1.56 Million
50.83%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding MDGL
# of Institutions
406Shares Held
23.1MCall Options Held
665KPut Options Held
514K-
Baker Bros. Advisors LP New York, NY2.14MShares$1.13 Billion8.0% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$1.06 Billion12.22% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.91MShares$1.01 Billion31.28% of portfolio
-
Janus Henderson Group PLC London, X01.84MShares$975 Million0.41% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.83MShares$970 Million11.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $9.05B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...